RT Journal Article
SR Electronic
T1 Doubling down on tumor suppressor deletion
JF Science Translational Medicine
FD American Association for the Advancement of Science
SP eaba2903
DO 10.1126/scitranslmed.aba2903
VO 12
IS 524
A1 Sowalsky, Adam G.
YR 2020
UL http://stm.sciencemag.org/content/12/524/eaba2903.abstract
AB Codeletion of BRCA2 and RB1 increases prostate cancer sensitivity to PARP inhibitor therapy.